SE8505047L - Fettemulsion - Google Patents

Fettemulsion

Info

Publication number
SE8505047L
SE8505047L SE8505047A SE8505047A SE8505047L SE 8505047 L SE8505047 L SE 8505047L SE 8505047 A SE8505047 A SE 8505047A SE 8505047 A SE8505047 A SE 8505047A SE 8505047 L SE8505047 L SE 8505047L
Authority
SE
Sweden
Prior art keywords
emulsion
fat emulsion
diagnositic
creaming
agglutination
Prior art date
Application number
SE8505047A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE8505047D0 (sv
Inventor
K A J Wretlind
B M Ajaxon
Original Assignee
Nutritional Int Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutritional Int Res Inst filed Critical Nutritional Int Res Inst
Priority to SE8505047A priority Critical patent/SE8505047L/
Publication of SE8505047D0 publication Critical patent/SE8505047D0/xx
Priority to EP86850372A priority patent/EP0220152A1/fr
Priority to NO864268A priority patent/NO864268L/no
Priority to DK510386A priority patent/DK510386A/da
Publication of SE8505047L publication Critical patent/SE8505047L/
Priority to US07/334,800 priority patent/US4970209A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE8505047A 1985-10-25 1985-10-25 Fettemulsion SE8505047L (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE8505047A SE8505047L (sv) 1985-10-25 1985-10-25 Fettemulsion
EP86850372A EP0220152A1 (fr) 1985-10-25 1986-10-23 Emulsion de graisse
NO864268A NO864268L (no) 1985-10-25 1986-10-24 Olje-i-vann-emulsjon.
DK510386A DK510386A (da) 1985-10-25 1986-10-24 Fedtemulsion af olie-i-vand-typen
US07/334,800 US4970209A (en) 1985-10-25 1989-04-03 Fat emulsions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8505047A SE8505047L (sv) 1985-10-25 1985-10-25 Fettemulsion

Publications (2)

Publication Number Publication Date
SE8505047D0 SE8505047D0 (sv) 1985-10-25
SE8505047L true SE8505047L (sv) 1987-04-26

Family

ID=20361920

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8505047A SE8505047L (sv) 1985-10-25 1985-10-25 Fettemulsion

Country Status (5)

Country Link
US (1) US4970209A (fr)
EP (1) EP0220152A1 (fr)
DK (1) DK510386A (fr)
NO (1) NO864268L (fr)
SE (1) SE8505047L (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5684050A (en) * 1986-01-24 1997-11-04 Hemagen/Pfc Stable emulsions of highly fluorinated organic compounds
US5514720A (en) * 1986-07-09 1996-05-07 Hemagen/Pfc Stable emulsions of highly fluorinated organic compounds
US5171755A (en) * 1988-04-29 1992-12-15 Hemagen/Pfc Emulsions of highly fluorinated organic compounds
KR920019370A (ko) 1991-04-26 1992-11-19 스야마 다다카즈 주입 제제
US5403575A (en) * 1991-12-12 1995-04-04 Hemagen/Pfc Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of using them
SE9203250D0 (sv) * 1992-11-03 1992-11-03 Kabi Pharmacia Ab Improved storage of oxygen sensitive materials
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
US5731355A (en) * 1994-03-22 1998-03-24 Zeneca Limited Pharmaceutical compositions of propofol and edetate
US20020173547A1 (en) 1994-03-22 2002-11-21 Jones Christopher Buchan Pharmaceuticals compositions
US5851510A (en) * 1994-05-16 1998-12-22 The Board Of Regents Of The University Of Michigan Hepatocyte-selective oil-in-water emulsion
US5693337A (en) * 1994-07-13 1997-12-02 Wakamoto Pharmaceutical Co., Ltd. Stable lipid emulsion
CN1106192C (zh) * 1995-03-17 2003-04-23 曾尼卡有限公司 含2,6－二异丙基苯酚和乙二胺四乙酸盐的水包油型乳液
CN100450473C (zh) * 1995-03-17 2009-01-14 曾尼卡有限公司 无菌医药组合物
TW410158B (en) * 1995-11-30 2000-11-01 Chemo Sero Therapeut Res Inst Oil adjuvant vaccine and method for preparing same
NO309795B1 (no) * 1998-07-01 2001-04-02 Norsk Hydro As FremgangsmOte for O stabilisere oljer samt anvendelse derav, fremgangsmOte for O stabilisere pigmenter, og fremgangsmOte for fremstilling av for
US20020155161A1 (en) * 2000-12-29 2002-10-24 Deckelbaum Richard J. Use of IV emulsions with different triglyceride composition, particle size and apolipoprotein E for targeted tissue delivery of hydrophobic compounds
EA200700440A1 (ru) * 2004-09-13 2008-02-28 Бхарат Сирумс Энд Вэксинс Лтд. Композиции стабильных эмульсий для внутривенного введения, имеющие защитную эффективность
WO2012096697A1 (fr) * 2011-01-14 2012-07-19 Simpkins Cuthbert O Procédés et compositions pour le traitement de maladies liées à un manque de réserve de sang, à un choc et à des lésions neuronales
JP5186050B1 (ja) * 2012-02-24 2013-04-17 謙輔 山川 皮下組織および皮下脂肪組織増加促進用組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2055083A (en) * 1932-07-13 1936-09-22 Winthrop Chem Co Inc Pharmaceutical preparation
DE1249454B (de) * 1960-08-26 1967-09-07 Vitrum Apoteksvar Verfahren zur Herstellung intravenoes verabreichbarer Fettemulsionen
GB1256162A (en) * 1968-08-16 1971-12-08 Braun Fa B Improvements in and relating to liquid products for intravenous administration
JPS537492B2 (fr) * 1973-02-12 1978-03-18
US4073943A (en) * 1974-09-11 1978-02-14 Apoteksvarucentralen Vitrum Ab Method of enhancing the administration of pharmalogically active agents
US4168308A (en) * 1976-03-12 1979-09-18 Apoteksvarucentralen Vitrum Ab Composition for enhancing the administration of pharmacologically active agents
IT1202370B (it) * 1976-07-12 1989-02-09 Hoffmann La Roche Soluzioni inietabili in cui l'atti vita' emolitica degli agenti di formazione di micelle naturali e' evitata mediante l'aggiunta di lipoidi e relativi prodotti
US4328222A (en) * 1978-11-21 1982-05-04 Hoffmann-La Roche Inc. Pharmaceutical compositions for parenteral or local administration
JPS6030652B2 (ja) * 1979-05-07 1985-07-17 株式会社ミドリ十字 静脈注射用脂肪乳剤
CA1173360A (fr) * 1979-06-22 1984-08-28 Jurg Schrank Produits pharmaceutiques
JPS5924132B2 (ja) * 1980-12-02 1984-06-07 株式会社 林原生物化学研究所 栄養補給用乳剤の製法
DE3131460A1 (de) * 1981-08-08 1983-02-24 B. Braun Melsungen Ag, 3508 Melsungen Fettemsulsion fuer parenterale ernaehrung
JPS59172416A (ja) * 1983-03-18 1984-09-29 Terumo Corp 脂肪輸液
JPS59193814A (ja) * 1983-04-20 1984-11-02 Ajinomoto Co Inc アミノ酸含有脂肪乳剤
CA1257131A (fr) * 1984-07-27 1989-07-11 John Y. Park Compose pour nutrition parenterale et enterale totale

Also Published As

Publication number Publication date
NO864268L (no) 1987-04-27
SE8505047D0 (sv) 1985-10-25
NO864268D0 (no) 1986-10-24
US4970209A (en) 1990-11-13
DK510386A (da) 1987-04-26
DK510386D0 (da) 1986-10-24
EP0220152A1 (fr) 1987-04-29

Similar Documents

Publication Publication Date Title
SE8505047L (sv) Fettemulsion
US4632980B1 (fr)
DE3480905D1 (de) Mittel zur transdermalen applikation von arzneistoffen.
AU1285592A (en) Methods for increasing extracellular adenosine and for stabilizing mast cells
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
DE68919146D1 (de) Ausgewählte Stämme von Lactobacillus enthaltende pharmazeutische Zusammensetzungen.
SE8902376D0 (sv) Foerfarande foer framstaellning av ett vaevnadsbindemedel
KR830002327A (ko) 약학적 제제
FI875533A (fi) Insulinpreparat foer non-parenteral dosering.
KR920703071A (ko) 지질 저하제로서 콜레스티라민을 함유하는 미세정제
DE3582439D1 (de) Mittel zur behandlung von herzerkrankungen.
NO862096L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende vevsplasminogenaktivator.
KR910002470A (ko) 혈관 x선 촬영 보조제
KR890012659A (ko) 조산아의 뇌실내 출혈방지용 치료제
IT1203671B (it) Reagente per la determinazione del la funzione di coagulazione del sangue e procedimento per la sua preparazione
DE3883044D1 (de) Wirkstoff zur tumorbekaempfung.
ES2031846T3 (es) Compuesto medico que contiene tpa y uso del mismo.
MA21895A1 (fr) Association de vitamine "a" a dose physiologique et differents principes actifs .
KR900017599A (ko) 종양 치료용 약학 조성물
DE3650368D1 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
AU5581186A (en) Protein absorption enhancing agent
ES2056801T3 (es) Oxirano-seudooligosacaridos, procedimiento para su preparacion, su utilizacion y preparados farmaceuticos.
Shimada et al. Clinical studies on serum lipids in the patients with tumor of the prostate gland. 3rd report: changes of serum lipid peroxide levels during estrogen therapy for prostatic cancer and therapeutic and preventive effect of riboflavin tetrabutylate for hyperlipidemia
JPS5283912A (en) Fat emulsion for intravenous injection
RU1835513C (ru) Устройство дл определени агрегационных свойств эритроцитов крови

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8505047-4

Effective date: 19921109